Issue 18, 2017, Issue in Progress

Highly stable and biocompatible W18O49@PEG-PCL hybrid nanospheres combining CT imaging and cancer photothermal therapy

Abstract

In this study, we encapsulated W18O49 NPs with PEG-PCL NPs (W18O49@PEG-PCL NPs). The PEG-PCL NPs enhance the biocompatibility, stability and internalization of the W18O49 NPs in cells. Retained for a long time, these W18O49@PEG-PCL NPs possess excellent CT efficiency and superior PTT potency, which confer them with the potential to play an active role in future clinical trials.

Graphical abstract: Highly stable and biocompatible W18O49@PEG-PCL hybrid nanospheres combining CT imaging and cancer photothermal therapy

Article information

Article type
Paper
Submitted
13 Dec 2016
Accepted
31 Jan 2017
First published
08 Feb 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 10692-10699

Highly stable and biocompatible W18O49@PEG-PCL hybrid nanospheres combining CT imaging and cancer photothermal therapy

J. Mu, X. Meng, L. Chen, Z. Lu, Q. Mou, X. Li, S. Wang and H. Yue, RSC Adv., 2017, 7, 10692 DOI: 10.1039/C6RA28161C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements